1. Home
  2. IHRT vs SPRY Comparison

IHRT vs SPRY Comparison

Compare IHRT & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iHeartMedia Inc.

IHRT

iHeartMedia Inc.

HOLD

Current Price

$2.81

Market Cap

589.5M

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$5.62

Market Cap

634.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IHRT
SPRY
Founded
1974
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
589.5M
634.5M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
IHRT
SPRY
Price
$2.81
$5.62
Analyst Decision
Sell
Strong Buy
Analyst Count
2
1
Target Price
$4.25
$40.00
AVG Volume (30 Days)
585.6K
1.5M
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
54.19
N/A
EPS
N/A
N/A
Revenue
$3,864,991,000.00
$84,278,000.00
Revenue This Year
$9.96
$87.40
Revenue Next Year
N/A
$81.64
P/E Ratio
N/A
N/A
Revenue Growth
0.27
N/A
52 Week Low
$2.05
$4.91
52 Week High
$6.56
$13.15

Technical Indicators

Market Signals
Indicator
IHRT
SPRY
Relative Strength Index (RSI) 40.40 43.72
Support Level $2.56 $5.04
Resistance Level $3.39 $6.58
Average True Range (ATR) 0.15 0.37
MACD 0.03 0.05
Stochastic Oscillator 49.53 35.14

Price Performance

Historical Comparison
IHRT
SPRY

About IHRT iHeartMedia Inc.

iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: